Penyuntingan gen CRISPR (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Penyuntingan gen CRISPR" in Malay language version.

refsWebsite

Global rank Malay rank

7nih.gov

4^th place

14^th place

6doi.org

2^nd place

8^th place

2science.org

1,160^th place

1,943^rd place

2wikipedia.org

low place

2harvard.edu

18^th place

46^th place

1nobelprize.org

301^st place

355^th place

1theconversation.com

928^th place

3,389^th place

1lrt.lt

5,044^th place

low place

1youtube.com

9^th place

26^th place

1sciencemag.org

857^th place

755^th place

1bbc.co.uk

8^th place

33^rd place

1gov.uk

432^nd place

1,368^th place

1fda.gov

447^th place

467^th place

bbc.co.uk

"Casgevy: UK approves gene-editing drug for sickle cell". BBC News. 16 November 2023. Dicapai pada 16 November 2023.

doi.org

"Gene Editing on Center Stage". Trends in Genetics. 34 (8): 600–611. August 2018. doi:10.1016/j.tig.2018.05.004. PMID 29908711. Ralat petik: Tag <ref> tidak sah, nama ":0" digunakan secara berulang dengan kandungan yang berbeza
"CRISPR, the revolutionary genetic "scissors," honored by Chemistry Nobel". Science. October 7, 2020. doi:10.1126/science.abf0540.
"Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter". Journal of Biotechnology. 189: 1–8. November 2014. doi:10.1016/j.jbiotec.2014.08.033. PMC 4252756. PMID 25193712. Unknown parameter |displayauthors= ignored (bantuan)
"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells". Nature Medicine. 24 (8): 1216–1224. August 2018. doi:10.1038/s41591-018-0137-0. PMC 6107069. PMID 30082871. Unknown parameter |displayauthors= ignored (bantuan)
"CRISPR: gene editing is just the beginning". Nature. 531 (7593): 156–159. March 2016. Bibcode:2016Natur.531..156L. doi:10.1038/531156a. PMID 26961639.
"CRISPR, the disruptor". Nature. 522 (7554): 20–24. June 2015. Bibcode:2015Natur.522...20L. doi:10.1038/522020a. PMID 26040877.

fda.gov

"FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease". Food and Drug Administration. 11 December 2023. Dicapai pada 11 December 2023.

gov.uk

"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Gov.uk. 16 November 2023. Dicapai pada 16 November 2023.

harvard.edu

ui.adsabs.harvard.edu

"CRISPR: gene editing is just the beginning". Nature. 531 (7593): 156–159. March 2016. Bibcode:2016Natur.531..156L. doi:10.1038/531156a. PMID 26961639.
"CRISPR, the disruptor". Nature. 522 (7554): 20–24. June 2015. Bibcode:2015Natur.522...20L. doi:10.1038/522020a. PMID 26040877.

lrt.lt

"Lithuanian scientists not awarded Nobel prize despite discovering same technology". LRT.LT. 8 October 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

"Gene Editing on Center Stage". Trends in Genetics. 34 (8): 600–611. August 2018. doi:10.1016/j.tig.2018.05.004. PMID 29908711. Ralat petik: Tag <ref> tidak sah, nama ":0" digunakan secara berulang dengan kandungan yang berbeza
"Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter". Journal of Biotechnology. 189: 1–8. November 2014. doi:10.1016/j.jbiotec.2014.08.033. PMC 4252756. PMID 25193712. Unknown parameter |displayauthors= ignored (bantuan)
"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells". Nature Medicine. 24 (8): 1216–1224. August 2018. doi:10.1038/s41591-018-0137-0. PMC 6107069. PMID 30082871. Unknown parameter |displayauthors= ignored (bantuan)
"CRISPR: gene editing is just the beginning". Nature. 531 (7593): 156–159. March 2016. Bibcode:2016Natur.531..156L. doi:10.1038/531156a. PMID 26961639.
"CRISPR, the disruptor". Nature. 522 (7554): 20–24. June 2015. Bibcode:2015Natur.522...20L. doi:10.1038/522020a. PMID 26040877.

ncbi.nlm.nih.gov

"Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter". Journal of Biotechnology. 189: 1–8. November 2014. doi:10.1016/j.jbiotec.2014.08.033. PMC 4252756. PMID 25193712. Unknown parameter |displayauthors= ignored (bantuan)
"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells". Nature Medicine. 24 (8): 1216–1224. August 2018. doi:10.1038/s41591-018-0137-0. PMC 6107069. PMID 30082871. Unknown parameter |displayauthors= ignored (bantuan)

nobelprize.org

"The Nobel Prize in Chemistry 2020". The Nobel Prize. Dicapai pada 2020-12-10.

science.org

"CRISPR, the revolutionary genetic "scissors," honored by Chemistry Nobel". Science. October 7, 2020. doi:10.1126/science.abf0540.
"With prestigious prize, an overshadowed CRISPR researcher wins the spotlight". Science | AAAS (dalam bahasa Inggeris). 2018-06-04. Dicapai pada 2020-05-02.

sciencemag.org

"Breakthrough of the Year: CRISPR makes the cut". Science Magazine. American Association for the Advancement of Science. 17 December 2015.

theconversation.com

"Nobel prize: who gets left out?". The Conversation. 8 October 2020. Dicapai pada 13 December 2021.

wikipedia.org

en.wikipedia.org

"Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter". Journal of Biotechnology. 189: 1–8. November 2014. doi:10.1016/j.jbiotec.2014.08.033. PMC 4252756. PMID 25193712. Unknown parameter |displayauthors= ignored (bantuan)
"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells". Nature Medicine. 24 (8): 1216–1224. August 2018. doi:10.1038/s41591-018-0137-0. PMC 6107069. PMID 30082871. Unknown parameter |displayauthors= ignored (bantuan)

youtube.com

"Imam genų žirkles, iškerpam klaidą, ligos nelieka". Laisvės TV / Freedom TV. 2018-06-16. 12:22 minit pada. LaisvėsTV. <...>Tai mes tą savo straipsnį išsiuntėm į redakciją pirmieji, bet laimės ten daug nebuvo. Viena redakcija pasakė, kad mes net recenzentam nesiųsim. Nusiuntėm į kitą redakciją – tai jis (straipsnis) pragulėjo kažkur ant redaktoriaus stalo labai ilgai. Na ir taip galų gale išsiuntėm į trečią žurnalą ir trečias žurnalas po kelių mėnesių jį išspausdino. Bet, aišku, Berklio universiteto mokslininkams sekėsi geriau – jie išsiuntė straipsnį į žurnalą Science – jį priėmė ir išspausdino per 2 savaites. Nors iš tikro jie tą straispnį išsiuntė pora mėnesių vėliau nei mes. Dicapai pada 2018-06-30. <...> Well, we were who had sent the article first, but had not much of luck.